Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial
Top Cited Papers
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9313) , 1178-1186
- https://doi.org/10.1016/s0140-6736(02)08214-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and OJournal of Clinical Microbiology, 2001
- Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/mLThe Journal of Infectious Diseases, 2001
- Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysisThe Lancet, 2000
- Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South AfricaAIDS, 1999
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trialThe Lancet, 1999
- Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, ThailandAIDS, 1999
- Estimating the Timing of Mother-to-Child Transmission of Human Immunodeficiency Virus in a Breast-Feeding Population in Kinshasa, ZaireThe Journal of Infectious Diseases, 1996
- Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South AfricaThe Pediatric Infectious Disease Journal, 1996
- Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II StudyThe Journal of Infectious Diseases, 1995